endocrinology
Hormones

Roll-on testosterone product exits market

The topical testosterone roll-on solution Axiron will no longer be available in Australia, after a licensing deal between its manufacturer and sole distributor was axed. In a letter to doctors, distributor Eli Lilly advises pharmacies will no longer be able to order the testosterone replacement therapy after December 4, when its licensing agreement with Melbourne-based pharmaceutical ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic